Fig 1.
ANC, absolute neutrophil count; ART, antiretroviral therapy.
Table 1.
Patient’s characteristics at ART initiation.
IeDEA West Africa collaboration, 2002–2015 (N = 9,426).
Fig 2.
Distribution of first-line antiretroviral regimens prescribed according to calendar period.
IeDEA West Africa collaboration, 2002–2014 (N = 9,426). ZDV, zidovudine; D4T, stavudine; NVP, nevirapine; TDF, tenofovir.
Table 2.
Incidence of severe neutropenia among 9,426 HIV-infected patients over a two-year period after ART initiation.
IeDEA West Africa collaboration, 2002–2015.
Table 3.
Cox regression univariate and multivariate models estimating risk of severe neutropenia within two years after ART initiation.
IeDEA West Africa collaboration, 2002–2014 (N = 9,426).
Table 4.
Distribution of antiretroviral modifications in HIV-infected patients with a first severe episode of neutropenia (n = 134).